Continuous Hemofiltration in 2009: What Is New for Clinicians Regarding Pathophysiology, Preferred Technique and Recommended Dose?

Publisher： Karger

E-ISSN： 1421-9735|28|2|135-143

ISSN： 0253-5068

Source： Blood Purification, Vol.28, Iss.2, 2009-07, pp. : 135-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Insights Regarding Rationale, Therapeutic Target and Dose of Hemofiltration and Hybrid Therapies in Septic Acute Kidney Injury

By  

Blood Purification, Vol. 33, Iss. 1-3, 2011-12 ,pp. : 44-51

Karger

Access to resources Recommend Favorite

Kinetics and Dose of Daily Hemofiltration

By  

Blood Purification, Vol. 22, Iss. 2, 2005-01 ,pp. : 14-19

Karger

Access to resources Recommend Favorite

Randomized Controlled Trial to Evaluate Regional Citrate Anticoagulation Plus Low-Dose of Dalteparin in Continuous Veno-Venous Hemofiltration

By  

Blood Purification, Vol. 39, Iss. 4, 2015-05 ,pp. : 306-312

Karger

Access to resources Recommend Favorite

Cytokine Removal in Septic Patients with Continuous Venovenous Hemofiltration

By  

Kidney and Blood Pressure Research, Vol. 26, Iss. 2, 2003-06 ,pp. : 128-134

Karger

Access to resources Recommend Favorite

Treatment of Life-Threatening Lithium Toxicity with High-Volume Continuous Venovenous Hemofiltration

By  

American Journal of Nephrology, Vol. 20, Iss. 5, 2000-11 ,pp. : 408-411

Karger

Access to resources Recommend Favorite